PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock

Delisted

PHAS was delisted on the 2nd of November, 2022.

61 hedge funds and large institutions have $110M invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$227K
Puts
$206K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$23M
2
$16.5M
3
$14.8M
4
$9.86M
5
$7.49M
6
$5.56M
7
$5.44M
8
$5.38M
9
$4.22M
10
$2.68M
11
$2.6M
12
$2.09M
13
$1.38M
14
$1.19M
15
$985K
16
$851K
17
$835K
18
$729K
19
$579K
20
$390K
21
$388K
22
$368K
23
$340K
24
$278K
25
$253K